Search

everythinglearnresearchcommunity

for

Search:↓

TrichoSolTM is safe for hair loss treatments with specific ingredient stability for up to 180 days.

Spironolactone with an oral contraceptive improved hair growth in women with hirsutism.

A woman poisoned with thallium was successfully treated with activated charcoal and Prussian blue.

Antiandrogen therapy may be beneficial for women with hidradenitis suppurativa.

Candida antigen is an effective and promising treatment for alopecia areata.

Oral betamethasone works faster than oral tofacitinib for hair regrowth in alopecia areata.

Azathioprine is the most continued treatment for chronic alopecia areata over a year, often with added low-dose prednisolone.

Spironolactone improved cognitive performance and early sleep quality but not manic symptoms, appetite, or body weight in bipolar disorder when added to sodium valproate.

New psoriasis treatments are effective but come with side effects and risks.

Para-aminobenzoic acid in hair supplements can cause autoimmune hepatitis.

The document concludes that new treatments are needed to better manage acne and reduce side effects related to current therapies.

The document concludes that adenosine receptor agonists have potential for treating various conditions, but only a few are approved due to challenges like side effects and the need for selective activation.

Spironolactone plus finasteride works better for treating hirsutism.

TH07 effectively promotes hair regrowth in androgenic alopecia with high patient satisfaction and no major side effects.

Antiandrogen therapies are beneficial for treating skin and hair conditions related to androgen levels.

Steroids may not work well for alopecia areata because of high unoccupied receptors and low thioredoxin levels.

Oral ritlecitinib and baricitinib are promising treatments for severe alopecia areata due to their balance of effectiveness and safety.

Taking vitamin D might improve life for MS patients and reduce skin side effects from alemtuzumab treatment.

Spironolactone may help reduce hair growth and testosterone levels in some women with hirsutism.

Phenytoin and spironolactone help prevent hair loss from chemotherapy by reducing stress and inflammation.

The new topical growth hormone formula has high skin penetration and bioavailability.

Treatment for benign prostatic hyperplasia involves drugs that either quickly relieve symptoms or reduce prostate size, with a combination offering more benefits but more side effects.

Antituberculous drugs improved symptoms in a woman with lupus and myositis.

The document concludes that various cosmetic and drug treatments are available for hirsutism, and some new drugs show promise.

A woman's severe skin reaction was caused by an allergy to a skin treatment.

Forsythoside A may help treat hair loss by blocking specific channels.

Combining TRA and latanoprost is most effective for treating localized alopecia areata.

Topical contact sensitizers can treat certain skin conditions but are rarely used in the U.K.

There is no clear recommendation for using selenium in cancer patients; it may be beneficial to correct low selenium levels before treatment.